Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH5 | P11766 | 7/20 | 0.41 |
| ▸ | ABL1 | P00519 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | CYP17A1 | P05093 | 2/20 | 0.35 |
| ▸ | PDE4A | P27815 | 1/20 | 0.35 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.35 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.35 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.35 |
| ▸ | KDM4D | Q6B0I6 | 1/20 | 0.35 |
| ▸ | BRD4 | O60885 | 1/20 | 0.35 |
| ▸ | KCNQ4 | P56696 | 1/20 | 0.34 |
| ▸ | KCNQ5 | Q9NR82 | 1/20 | 0.34 |
| ▸ | TNIK | Q9UKE5 | 1/20 | 0.34 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7143394 | 0.92 | ADH5 (0.40) | ADH5ABL1L3MBTL1CYP17A1PDE4A | |
| SCHEMBL7139934 | 0.91 | ABL1 (0.41) | ADH5ABL1L3MBTL1CYP17A1PDE4A | |
| SCHEMBL7147242 | 0.91 | ABL1 (0.41) | ADH5ABL1L3MBTL1CYP17A1PDE4A | |
| SCHEMBL5868869 | 0.90 | ADH5 (0.41) | ADH5ABL1L3MBTL1CYP17A1PDE4A | |
| SCHEMBL5868843 | 0.90 | CYP17A1 (0.42) | ABL1L3MBTL1CYP17A1PDE4APDE4B | |
| SCHEMBL7139808 | 0.90 | ABL1 (0.39) | ADH5ABL1L3MBTL1CYP17A1PDE4A | |
| SCHEMBL7140968 | 0.89 | ABL1 (0.38) | ADH5ABL1L3MBTL1CYP17A1PDE4A | |
| SCHEMBL7145856 | 0.88 | ABL1 (0.38) | ADH5ABL1L3MBTL1CYP17A1PDE4A | |
| SCHEMBL7145881 | 0.88 | ABL1 (0.39) | ADH5ABL1L3MBTL1CYP17A1PDE4A | |
| SCHEMBL7141902 | 0.88 | ABL1 (0.37) | ADH5ABL1L3MBTL1CYP17A1PDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1224174-B1 | BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | HOFFMANN LA ROCHE (CH) | 2003-09-17 | — | — | EP | disclosed |
| EP-1224174-A2 | BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2002-07-24 | — | — | EP | disclosed |
| US-6407094-B1 | 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA | HOFFMANN-LA ROCHE INC. | 2002-06-18 | — | — | US | disclosed |
| WO-2001029011-A2 | BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2001-04-26 | — | — | WO | disclosed |